Catalyst Pharmaceuticals Competitors and Similar CompaniesClear all

Catalyst Pharmaceuticals's competitors and similar companies include Alnylam and ANI Pharmaceuticals.
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases.
Alnylam
Alnylam
Alnylam is a biopharmaceutical company that develops ribonucleic acid interference (RNAi) therapeutics for hepatic porphyria, primary hyperoxaluria type 1 (PH1), cardiovascular, and polyneuropathy treatments.
ANI Pharmaceuticals
ANI Pharmaceuticals
ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A.
Founding Date
Founding Date
2002
Founding Date
2002
Founding Date
1996
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Coral Gables, US HQ
Locations
Cambridge, US HQ
Paris, FR
Milan, IT
Tokyo, JP
Amsterdam, NL
Stockholm, SE
Zug, CH
see more
Locations
Baudette, US HQ
Oakville, CA
Baudette, US
Employees
Employees
7649% increase
Employees
1,32324% increase
Employees
33813% increase
Valuation ($)
Valuation ($)
2.6 b
Valuation ($)
36.5 b
Valuation ($)
1.2 b

Financial

Revenue (est.)
Revenue (est.)
$589m (FY, 2025)
Revenue (est.)
$3.7b (FY, 2025)
Revenue (est.)
$883.4m (FY, 2025)
Cost of goods
Cost of goods
$87.3m (FY, 2025)
Cost of goods
$677.2m (FY, 2025)
Cost of goods
N/A
Gross profit
Gross profit
$501.7m (FY, 2025)
Gross profit
$3b (FY, 2025)
Gross profit
N/A
Net income
Net income
$214.3m (FY, 2025)
Net income
$313.7m (FY, 2025)
Net income
N/A
For sources of this data, please see the company profile

View Company Profiles

Alnylam
HQ
Cambridge, US
Employees
1,323↑ 24% increase

Alnylam is a biopharmaceutical company that develops ribonucleic acid interference (RNAi) therapeutics for hepatic porphyria, primary hyperoxaluria type 1 (PH1), cardiovascular, and polyneuropathy treatments.

View company
ANI Pharmaceuticals
HQ
Baudette, US
Employees
338↑ 13% increase

ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A.

View company